DK0721470T3 - Monoklonale antistoffer der er nyttige til diagnosticering og behandling af colorektal kræft - Google Patents

Monoklonale antistoffer der er nyttige til diagnosticering og behandling af colorektal kræft

Info

Publication number
DK0721470T3
DK0721470T3 DK94923816T DK94923816T DK0721470T3 DK 0721470 T3 DK0721470 T3 DK 0721470T3 DK 94923816 T DK94923816 T DK 94923816T DK 94923816 T DK94923816 T DK 94923816T DK 0721470 T3 DK0721470 T3 DK 0721470T3
Authority
DK
Denmark
Prior art keywords
pct
chain
sequence
human
residues
Prior art date
Application number
DK94923816T
Other languages
English (en)
Inventor
Lorna Mary Dyet Stewart
Walter Fred Bodmer
Helga Durbin
David Snary
Susan Young
Paul Alan Bates
Original Assignee
Cancer Rec Tech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Rec Tech Ltd filed Critical Cancer Rec Tech Ltd
Application granted granted Critical
Publication of DK0721470T3 publication Critical patent/DK0721470T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3046—Stomach, Intestines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3007—Carcino-embryonic Antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK94923816T 1993-08-21 1994-08-19 Monoklonale antistoffer der er nyttige til diagnosticering og behandling af colorektal kræft DK0721470T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939317423A GB9317423D0 (en) 1993-08-21 1993-08-21 Monoclonal antibodies
PCT/GB1994/001816 WO1995006067A1 (en) 1993-08-21 1994-08-19 Monoclonal antibodies for use in diagnosis and treatment of colorectal cancer

Publications (1)

Publication Number Publication Date
DK0721470T3 true DK0721470T3 (da) 2003-02-24

Family

ID=10740834

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94923816T DK0721470T3 (da) 1993-08-21 1994-08-19 Monoklonale antistoffer der er nyttige til diagnosticering og behandling af colorektal kræft

Country Status (12)

Country Link
US (1) US5965710A (da)
EP (1) EP0721470B1 (da)
JP (1) JP3492373B2 (da)
AT (1) ATE226596T1 (da)
AU (1) AU7390694A (da)
CA (1) CA2168440C (da)
DE (1) DE69431602T2 (da)
DK (1) DK0721470T3 (da)
ES (1) ES2187529T3 (da)
GB (1) GB9317423D0 (da)
PT (1) PT721470E (da)
WO (1) WO1995006067A1 (da)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5872215A (en) * 1991-12-02 1999-02-16 Medical Research Council Specific binding members, materials and methods
GB9621295D0 (en) * 1995-12-07 1996-11-27 Cambridge Antibody Tech Specific binding members,materials and methods
US6417337B1 (en) * 1996-10-31 2002-07-09 The Dow Chemical Company High affinity humanized anti-CEA monoclonal antibodies
WO1999006834A2 (en) * 1997-08-04 1999-02-11 Ixsys, Incorporated Methods for identifying ligand specific binding molecules
DE19739685A1 (de) * 1997-09-10 1999-03-11 Eichel Streiber Christoph Von Monoklonale Antikörper zur Therapie und Prophylaxe von Erkrankungen durch Clostridium difficile
AU6940700A (en) * 1999-08-26 2001-03-19 Amy P. N Skubitz Peptides capable of modulating the function of cd66 (ceacam) family members
US6835549B2 (en) * 2000-02-24 2004-12-28 University Of Medicine & Dentistry Of New Jersey Immunoassay method for the diagnosis of gastric intestinal metaplasia associated with gastric carcinoma
US6774209B1 (en) 2000-04-03 2004-08-10 Dyax Corp. Binding peptides for carcinoembryonic antigen (CEA)
EP1472276A4 (en) * 2001-02-28 2007-05-09 Keith M Skubitz PEPTIDES OF SMALL SIZE CAPACITY TO MODULATE THE FUNCTION OF THE MEMBERS OF THE FAMILY OF CD66 (CEACAM)
CA2439402A1 (en) * 2001-03-02 2002-09-12 University Of Pittsburgh Of The Commonwealth System Of Higher Education Pcr method
PT2000545E (pt) * 2001-06-20 2011-12-21 Genentech Inc Composições e métodos para o diagnóstico e tratamento do tumor pulmonar
US20040229215A1 (en) * 2003-03-04 2004-11-18 Auburn University Methods of forming monolayers of phage-derived products and uses thereof
WO2005114444A1 (en) * 2004-04-30 2005-12-01 America Online, Inc. Network configuration management
US8187595B2 (en) 2004-05-07 2012-05-29 The University Of North Carolina At Chapel Hill Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor-I
AU2005286876A1 (en) * 2004-09-20 2006-03-30 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Multiple mode multiplex reaction quenching method
KR101527334B1 (ko) 2005-08-11 2015-06-09 알피 마토씨안-로저스 자가면역 질병의 치료 및 진단용 ｔｃｒ-ｖ-베타 관련 펩티드
EP1940355B1 (en) 2005-09-30 2012-12-19 Auburn University Targeted drug delivery nanocarrier comprising a targeting landscape phage protein assembly
US8119352B2 (en) * 2006-06-20 2012-02-21 Cepheld Multi-stage amplification reactions by control of sequence replication times
AU2008351621B2 (en) * 2008-02-29 2013-05-09 Signalomics Gmbh Optimized adhesin fragments and corresponding nanoparticles
KR101528013B1 (ko) * 2009-08-31 2015-06-16 로슈 글리카트 아게 친화성-성숙된 인간화된 항-ｃｅａ 단일클론 항체
CA2773515C (en) * 2009-09-29 2015-04-28 Roche Glycart Ag Bispecific death receptor agonistic antibodies
WO2011109769A1 (en) 2010-03-04 2011-09-09 Ventana Medical Systems, Inc. Processing system for processing specimens using acoustic energy
US10539487B2 (en) 2010-03-04 2020-01-21 Ventana Medical Systems, Inc. Systems and methods for monitoring tissue sample processing
US10126216B2 (en) 2011-02-17 2018-11-13 Ventana Medical Systems, Inc. Method for tissue sample fixation
PE20141017A1 (es) * 2011-03-02 2014-08-25 Roche Glycart Ag Anticuerpos del cea
EA201892619A1 (ru) 2011-04-29 2019-04-30 Роше Гликарт Аг Иммуноконъюгаты, содержащие мутантные полипептиды интерлейкина-2
CA2882757A1 (en) * 2012-08-31 2014-03-06 The University Of North Carolina At Chapel Hill Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor 1 (igf-1)
UA118028C2 (uk) 2013-04-03 2018-11-12 Рош Глікарт Аг Біспецифічне антитіло, специфічне щодо fap і dr5, антитіло, специфічне щодо dr5, і спосіб їх застосування
US9753036B2 (en) 2014-04-29 2017-09-05 Edp Biotech Corporation Methods and compositions for screening and detecting biomarkers
KR20250024741A (ko) 2022-03-23 2025-02-19 시나픽스 비.브이. 암배아성 항원을 발현하는 종양을 표적화하기 위한 항체-컨쥬게이트

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU625613B2 (en) * 1988-01-05 1992-07-16 Novartis Ag Novel chimeric antibodies

Also Published As

Publication number Publication date
WO1995006067A1 (en) 1995-03-02
DE69431602T2 (de) 2003-06-26
DE69431602D1 (de) 2002-11-28
AU7390694A (en) 1995-03-21
EP0721470B1 (en) 2002-10-23
JPH09501571A (ja) 1997-02-18
PT721470E (pt) 2003-03-31
ATE226596T1 (de) 2002-11-15
EP0721470A1 (en) 1996-07-17
ES2187529T3 (es) 2003-06-16
CA2168440A1 (en) 1995-03-02
JP3492373B2 (ja) 2004-02-03
GB9317423D0 (en) 1993-10-06
US5965710A (en) 1999-10-12
CA2168440C (en) 2002-07-23

Similar Documents

Publication Publication Date Title
DK0721470T3 (da) Monoklonale antistoffer der er nyttige til diagnosticering og behandling af colorektal kræft
HRP20020693B1 (hr) HUMANIZIRANA PROTUTIJELA KOJA SADRŽE PEPTID Aß
PT699237E (pt) Fvs de cadeia anti-egfr e anticorpos anti-egfr
RU2006107453A (ru) Полипептидные композиции, связывающие cd20
GB2246781A (en) CD3 specific recombinant antibody
CO5280086A1 (es) Molecula de enlace de cd154, construccion de adn, vector de expresion, composcion y combinacion farmaceutica
EP1362868A3 (en) Humanized and chimeric monoclonal antibodies that bind epidermal growth factor receptor (EGF-R)
DK0667902T3 (da) CDR-graftede humaniserede, kimæriske T-celle-antistoffer
ES2106195T3 (es) Anticuerpo igg aglicosilado anti cd3.
NO20066052L (no) Anti-CD3 antistoffer og fremgangsmater for anvendelse derav
EA200301098A1 (ru) Ассоциированные с ганглиозидами рекомбинантные антитела и их применение в диагностике и лечении опухолей
ATE427966T1 (de) Stimulation einer immunantwort durch antikírper, welche mit dem alpha-galaktosylepitop markiert sind
LU90383I2 (fr) Simulect (inn:basiliximab)
NZ614727A (en) Human antibodies that bind human tnfa
TR199902553T2 (xx) �nsan v�cuduna kar�� antijen resept�rlerinin �retimi i�in yeni metod ve kullan�mlar�.
KR960704938A (ko) Fas 길항제 및 그의 용도(Fas Antagonists and Uses Thereof)
HUP9901562A2 (hu) Anti-CEA monoklonális antitestek, az ezeket tartalmazó konjugátumok és ezek felhasználása antitest irányított enzimes előgyógyszer terápiában
IL280487B2 (en) Anti-mica/b antibodies that block mica/b shedding and methods of use
KR940006602A (ko) 면역글로불린 이소타입에 대한 재조형 모노클로날 항체
DE3775182D1 (de) Monoklonale antikoerper gegen menschliche ige-rezeptoren auf lymphocyten, diese antikoerper produzierende hybridomas und reaktionsansaetze zum gebrauch dieser antikoerper.
ATE125305T1 (de) Monoklonale antikörper von ratten gegen menschliche antigene und verfahren zu deren herstellung.
HUT75824A (en) A novel endothelial cell molecule mediating lymphocyte binding in man
RU2024125098A (ru) Антитела, специфичные к нектину-4 человека
RU2023128561A (ru) Gucy2c-связывающий полипептид и его применение
PT101652A (pt) Anticorpos monoclonais anti-igm e metodos para a sua utilizacao